搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
搜狐
3 天
甄师选课 |《TED—The best presentation skill》(TED演讲技巧)
平台声明:该文观点仅代表作者本人,搜狐号系信息发布平台,搜狐仅提供信息存储空间服务。
10 天
Viridian股票在H.C. Wainwright维持买入评级,TED药物数据更新后
周三,H.C. Wainwright在Viridian Therapeutics (NASDAQ:VRDN)宣布THRIVE-1研究的积极结果后,维持了其买入评级和27.00美元的目标价。Viridian Therapeutics于9月10日报告,其药物VRDN-001在治疗甲状腺眼病 (TED)方面显示出有希望的结果,在某些指标上可能优于当前领先的治疗药物Tepezza。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Secret Service admits failure
Released after guilty plea
Sesame Place suit verdict
Pandas leaving for China
Jurors begin deliberations
SC 1st execution in 13 years
Drug price challenge revived
Boeing defense chief exits
Feds subpoena Schaeffer
TN abortion law blocked
WI high court to decide
Russia threatens retaliation
FDA approves flu vaccine
Body found in SUV
144K+ Mavericks recalled
House repeals emission rules
Hand count approved in GA
Bill to boost security OK'd
In-person voting begins
$230 million crypto theft
Sues pharmacy middlemen
Top Hezbollah leader killed?
Hiker injured in bear attack
Baby powder recalled
1st rabies outbreak in seals
MS sheriff's office probe
Stein's ballot bid rejected
Recalling 449K+ vehicles
Disney to stop using Slack
$3B for battery projects
反馈